Pharmaceuticals

Angina Pectoris Drugs Market 2025–2029: Strategic Opportunities and Growth Insights

December 3, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the angina pectoris drugs market from 2025–2034 with trusted insights from The Business Research Company

What Are The Market Size Estimates For The Angina Pectoris Drugs Market Now And By 2029?

The angina pectoris drugs market size has shown consistent expansion in recent years. Projections indicate it will increase from $12.32 billion in 2024 to $12.88 billion in 2025, achieving a compound annual growth rate (CAGR) of 4.5%. Historically, this expansion can be linked to the widespread occurrence of cardiovascular diseases, the demographics of an aging population, various lifestyle elements, rising hypertension rates, and the prevalence of diabetes.

The angina pectoris drugs market is anticipated to show significant expansion over the next few years. It is predicted to grow to $16.42 billion in 2029, achieving a compound annual growth rate (CAGR) of 6.3%. This projected growth during the forecast period stems from escalating global obesity rates, breakthroughs in precision medicine, a greater focus on preventive cardiology, initiatives aimed at patient education, and ongoing research into novel therapeutic targets. Prominent trends expected in the forecast period involve the utilization of telemedicine for remote surveillance, real-world evidence collection and outcome studies, educational approaches centered on patients for medication, strategic partnerships to facilitate market access, advancements in regulatory practices, and accelerated approval procedures.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10797&type=smp

Which Long-Term Drivers Are Expected To Sustain The Angina Pectoris Drugs Market?

The rising incidence of cardiovascular conditions is projected to drive the expansion of the angina pectoris drug market in the future. These diseases include various disorders affecting the heart and blood vessels, such as coronary artery disease, high blood pressure, heart failure, and stroke. This growing prevalence of cardiovascular diseases can be linked to multiple factors, including an older demographic, poor lifestyle choices, and the widespread issue of obesity. Medications for angina pectoris, including nitrates, beta-blockers, and calcium channel blockers, are effective in alleviating chest pain and discomfort resulting from inadequate blood supply to the heart, consequently improving patients’ overall quality of life. For example, data released in September 2024 by the British Heart Foundation, a UK-based cardiovascular research charity, indicates that in the UK, roughly 7.6 million individuals are impacted by heart and circulatory diseases, comprising about 4 million males and 3.6 million females. These ailments account for approximately 27% of all fatalities in the UK, amounting to more than 170,000 deaths each year, or around 480 deaths daily, which signifies one death every three minutes. Consequently, the rising incidence of cardiovascular diseases is fueling the expansion of the angina pectoris drug market.

How Is The Angina Pectoris Drugs Market Classified By Different Segments?

The angina pectoris drugs market covered in this report is segmented –

1) By Drugs: Nitrates, Antiplatelet Agents, Beta-adrenergic Blocking Agents, Calcium Channel Blockers, Anti-ischemic Agents, Statins, Antihypertensive Agents, Other Drugs

2) By Indication: Stable Angina, Unstable Angina, Prinzmetal’s Angina

3) By Route of Administration: Oral, Parenteral, Transdermal, Other Route Of Administrations

4) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users

Subsegments:

1) By Nitrates: Short-Acting Nitrates, Long-Acting Nitrates

2) By Antiplatelet Agents: Aspirin, Clopidogrel

3) By Beta-Adrenergic Blocking Agents: Non-Selective Beta Blockers, Selective Beta Blockers

4) By Calcium Channel Blockers: Dihydropyridine Calcium Channel Blockers, Non-dihydropyridine Calcium Channel Blockers

5) By Anti-Ischemic Agents: Ranolazine, Ivabradine

6) By Statins: Atorvastatin, Rosuvastatin

What Current And Upcoming Trends Are Shaping The Angina Pectoris Drugs Market?

Product innovation represents a prominent trend gaining traction within the angina pectoris drugs market. Major companies operating in the angina pectoris drug market are adopting new technologies to sustain their position in the market. As an example, in March 2023, Hikma Pharmaceuticals PLC, a UK-based pharmaceutical company, launched Labetalol Hydrochloride Injection, USP, provided in a prefilled syringe. The Food and Drug Administration of the United States has authorized this product. In hospitals, the 10 mg/2 mL PFS is utilized for addressing severe hypertension and lowering blood pressure.

Who Are The Primary Market Leaders In The Angina Pectoris Drugs Market?

Major companies operating in the angina pectoris drugs market include Astellas Pharma Inc., Bayer AG, Novartis AG, AstraZeneca PLC, Bausch Health Companies Inc., Merck & Co Inc., Eli Lilly and Company, Pfizer Inc., Abbott Laboratories, Sun Pharmaceutical Industries Limited, Sanofi SA, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Johnson & Johnson, AERIE PHARMACEUTICALS INC., AbbVie Inc., Amgen Inc., Gilead Sciences Inc., GlaxoSmithKline plc, H. Lundbeck A/S, Ipsen S.A., Lupin Pharmaceuticals Inc., Merck KGaA, Otsuka Pharmaceutical Co. Ltd., Regeneron Pharmaceuticals Inc., Servier Laboratories, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., UCB S.A.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/angina-pectoris-drugs-global-market-report

Which Regional Markets Are Emerging As Key Centers For The Angina Pectoris Drugs Market?

North America was the largest region in the angina pectoris drugs market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the angina pectoris drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=10797&type=smp

Browse Through More Reports Similar to the Global Angina Pectoris Drugs Market 2025, By The Business Research Company

Muscle Relaxant Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/muscle-relaxant-drugs-global-market-report

Alzheimers Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/alzheimers-drugs-global-market-report

Osteoporosis Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/osteoporosis-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795